KUALA LUMPUR (Dec 7): MY E.G. Services Bhd (MYEG) announced today that it has entered into a cooperation with Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. (Zhifei) to obtain Malaysian Halal certification for the Chinese biopharma company’s COVID-19 vaccine and to exclusively distribute the vaccine in Malaysia for a 3-year period.

In a statement today, MYEG said the two companies have signed a Memorandum of Understanding, agreeing to cooperate in conducting Phase 3 clinical trials of Zhifei’s vaccine in Malaysia and in achieving compliance to Halal status requirements to secure Halal certification from the Department of Islamic Development Malaysia (JAKIM).

MYEG said the commencement of Phase 3 trial will make Zhifei’s vaccine one of the first to undergo this final stage trial in Malaysia under the purview of the Ministry of Health.

Zhifei is a subsidiary of Chongqing Zhifei Biological Products Co., Ltd., which is listed on the Shenzhen Stock Exchange and has been engaged in the biological products industry since 2002, mainly the production of vaccines for human use. Zhifei is presently one of five Chinese companies conducting Phase 3 clinical trials of their COVID-19 vaccines in various parts of the world.

Upon successful completion of the Phase 3 trials, MYEG will be the sole distributor of the vaccine in Malaysia.

Since Nov 1, 2020, MYEG has been appointed by the Malaysian Ministry of Health to develop and operate the MySafeTravel digital health pass system to facilitate inbound travellers’ compliance to mandatory COVID-19 testing and quarantine requirements.

In addition, MYEG also operates a one-stop portal for the COVID-19 screening of workers in the country, which includes a data sharing collaboration with the Department of Labour of Peninsular Malaysia.

MYEG was last traded at RM1.81, valuing it at RM6.61 billion.

KUALA LUMPUR (Dec 7): MY E.G. Services Bhd (MYEG) announced today that it has entered into a cooperation with Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. (Zhifei) to obtain Malaysian Halal certification for the Chinese biopharma company’s COVID-19 vaccine and to exclusively distribute the vaccine in Malaysia for a 3-year period.

In a statement today, MYEG said the two companies have signed a Memorandum of Understanding, agreeing to cooperate in conducting Phase 3 clinical trials of Zhifei’s vaccine in Malaysia and in achieving compliance to Halal status requirements to secure Halal certification from the Department of Islamic Development Malaysia (JAKIM).

MYEG said the commencement of Phase 3 trial will make Zhifei’s vaccine one of the first to undergo this final stage trial in Malaysia under the purview of the Ministry of Health.

Zhifei is a subsidiary of Chongqing Zhifei Biological Products Co., Ltd., which is listed on the Shenzhen Stock Exchange and has been engaged in the biological products industry since 2002, mainly the production of vaccines for human use. Zhifei is presently one of five Chinese companies conducting Phase 3 clinical trials of their COVID-19 vaccines in various parts of the world.

Upon successful completion of the Phase 3 trials, MYEG will be the sole distributor of the vaccine in Malaysia.

Since Nov 1, 2020, MYEG has been appointed by the Malaysian Ministry of Health to develop and operate the MySafeTravel digital health pass system to facilitate inbound travellers’ compliance to mandatory COVID-19 testing and quarantine requirements.

In addition, MYEG also operates a one-stop portal for the COVID-19 screening of workers in the country, which includes a data sharing collaboration with the Department of Labour of Peninsular Malaysia.

MYEG was last traded at RM1.81, valuing it at RM6.61 billion.

@ ymccccm 7 : Heard from UOB Kay Hian.. MYEG will be awarded NIIS soon

https://www.theedgemarkets.com/article/myeg-inks-3year-cooperation-zhifei-obtain-jakim-certification-and-distribute-covid-vaccine

https://www.theedgemarkets.com/article/myeg-inks-3year-cooperation-zhifei-obtain-jakim-certification-and-distribute-covid-vaccine

rading Halt and Resumption of Trading

MY E.G. SERVICES BERHAD

Kindly be advised that trading in MYEG's securities has been halted with effect from 9.00 a.m., Monday, 7 December 2020.



Trading in the above securities will resume with effect from 10.00 a.m., Monday, 7 December 2020.



Your attention is drawn to MYEG's announcement dated 7 December 2020.

https://www.theedgemarkets.com/article/myeg-inks-3year-cooperation-zhifei-obtain-jakim-certification-and-distribute-covid-vaccine

Next TP 2.20

Yes Orson. Next Tp Dsonic 0.40

Lida Rashid jangan Mimpi la....

KUALA LUMPUR (Dec 4): MyEG Services Bhd (MyEG) has secured a three-year extension for the e-government services it provides.

In a bourse filing today, the group said the Ministry of Transport (MoT) had granted the extension from May 23, 2020 to May 22, 2023.

It said the extension is in the best interest of the company, and expected to contribute positively to earnings and net assets per share of the company for the financial year ending Dec 31, 2020 (FY20) and thereafter.

“An agreement to formalise the extension will be signed and announced by the company in due course,” it said.

On May 23, 2000, MyEG entered into a concession agreement with the government for the electronic delivery of driver and vehicle registration, licensing and summons services, and utility bill payments (e-services) for a minimum tenure of 15 years.

On May 21, 2020, the group received an official notification from the government to continue with the provision of the e-government services until June 30, 2020.

At the noon break today, MyEG was 18 sen or 10.84% higher at RM1.84, valuing the group at RM6.25 billion. It was among the top gainers in the morning session today.

Resin price up 20-25 % & face mask were over supply now. Too many producers

KUALA LUMPUR (Dec 4): MyEG Services Bhd (MyEG) has secured a three-year extension for the e-government services it provides.

In a bourse filing today, the group said the Ministry of Transport (MoT) had granted the extension from May 23, 2020 to May 22, 2023.

It said the extension is in the best interest of the company, and expected to contribute positively to earnings and net assets per share of the company for the financial year ending Dec 31, 2020 (FY20) and thereafter.

“An agreement to formalise the extension will be signed and announced by the company in due course,” it said.

On May 23, 2000, MyEG entered into a concession agreement with the government for the electronic delivery of driver and vehicle registration, licensing and summons services, and utility bill payments (e-services) for a minimum tenure of 15 years.

On May 21, 2020, the group received an official notification from the government to continue with the provision of the e-government services until June 30, 2020.

At the noon break today, MyEG was 18 sen or 10.84% higher at RM1.84, valuing the group at RM6.25 billion. It was among the top gainers in the morning session today.

KUALA LUMPUR (Dec 4): MyEG Services Bhd (MyEG) has secured a three-year extension for the e-government services it provides.

In a bourse filing today, the group said the Ministry of Transport (MoT) had granted the extension from May 23, 2020 to May 22, 2023.

It said the extension is in the best interest of the company, and expected to contribute positively to earnings and net assets per share of the company for the financial year ending Dec 31, 2020 (FY20) and thereafter.

“An agreement to formalise the extension will be signed and announced by the company in due course,” it said.

On May 23, 2000, MyEG entered into a concession agreement with the government for the electronic delivery of driver and vehicle registration, licensing and summons services, and utility bill payments (e-services) for a minimum tenure of 15 years.

On May 21, 2020, the group received an official notification from the government to continue with the provision of the e-government services until June 30, 2020.

At the noon break today, MyEG was 18 sen or 10.84% higher at RM1.84, valuing the group at RM6.25 billion. It was among the top gainers in the morning session today.

KUALA LUMPUR (Dec 4): MyEG Services Bhd (MyEG) has secured a three-year extension for the e-government services it provides.

In a bourse filing today, the group said the Ministry of Transport (MoT) had granted the extension from May 23, 2020 to May 22, 2023.

It said the extension is in the best interest of the company, and expected to contribute positively to earnings and net assets per share of the company for the financial year ending Dec 31, 2020 (FY20) and thereafter.

“An agreement to formalise the extension will be signed and announced by the company in due course,” it said.

On May 23, 2000, MyEG entered into a concession agreement with the government for the electronic delivery of driver and vehicle registration, licensing and summons services, and utility bill payments (e-services) for a minimum tenure of 15 years.

On May 21, 2020, the group received an official notification from the government to continue with the provision of the e-government services until June 30, 2020.

At the noon break today, MyEG was 18 sen or 10.84% higher at RM1.84, valuing the group at RM6.25 billion. It was among the top gainers in the morning session today.

Post removed.Why?

Post removed.Why?

Post removed.Why?

Post removed.Why?

Next TP 5

You are right

Tp over 2

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3111128

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3111128

MyEG获交通部延长3年合约

MyEG（MYEG，0138，主板科技股）获得交通部延长数字电子政府服务合约3年。

https://www.enanyang.my/node/370314

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3111128

Go go up up

Close at 2.06 not bad not bad. I am hold tight

I will hold

Vaccine-related: Following the approval of Budget 2021, vaccine-related companies will benefit under the Covid-19 fund/fill-and-finish process as well as distribution of vaccines once it is available in the future. Under this segment, SOLUTN, HWGB, BINTAI, DPHARMA, PHARMA, KANGER, -Ahealth, TITIJYA, MAHSING should be under traders radar.

Source: M+ Online

Vaccine-related: Following the approval of Budget 2021, vaccine-related companies will benefit under the Covid-19 fund/fill-and-finish process as well as distribution of vaccines once it is available in the future. Under this segment, SOLUTN, HWGB, BINTAI, DPHARMA, PHARMA, KANGER, TITIJYA, MAHSING should be under traders radar.

Source: M+ Online

PMB TECHNOLOGY BERHAD (“PMBT” OR “THE COMPANY”)

- MEMORANDUM OF UNDERSTANDING BETWEEN PMBT AND PERBADANAN PEMBANGUNAN EKONOMI SARAWAK

1. Introduction

The Board of Directors of PMBT is pleased to announce that the Company has on 26 November 2020, entered into a memorandum of understanding (“MOU”) with Perbadanan Pembangunan Ekonomi Sawarak (otherwise known as Sarawak Economic Development Corporation) (“SEDC”) to explore the potential collaboration for the development and operation of an integrated siloxane plant in Tanjung Kidurong, Bintulu, Sarawak.

2. Details of the MOU

2.1 The main objectives of the MOU are as follows:-

a) To promote the commercial, industrial and socio-economic development of Sarawak through the prospective development and operation of an integrated siloxane plant in Tanjung Kidurong, Bintulu, Sarawak (“the Project”) which shall be located immediately adjacent to the Methanol Plant (“the Proposed Site”);

b) To explore the prospective of securing a long-term but at arms’ length supply of the two (2) key raw materials required for the Project, which are methanol and silicon metal from 1Sarawak Petchem Sdn. Bhd. [Registration No. 201701020117 (1234282X)] (“SPSB”) and 2PMB Silicon Sdn. Bhd. [Registration No. 201601011055 (1181986-X) (“PMBS”)] respectively, which in turns help retain jobs for the local market;

c) To identify and work with other suitable partners/shareholders for the Project;

d) To manufacture siloxane locally to create jobs for the local market and to develop local technical skills and talents; and

e) To supply siloxane to both the local and international markets so as to raise the standing of Sarawak, Malaysia.

Notes:-

1 SPSB has been granted an approval by the Sarawak Government to set up a methanol complex on Lot 3396 Block
2

20 Kemena Land District, Kidurong/Similajau Road, Bintu

MYEG resistance points anticipated at RM1.70 and RM1.75.

MYEG developing a consolidation phase, says RHB Retail Research - http://www.theedgemarkets.com/article/myeg-developing-consolidation-phase-says-rhb-retail-research (Share from StockHunter)

MYEG resistance points anticipated at RM1.70 and RM1.75.

resistance points anticipated at RM1.70 and RM1.75.

MYEG developing a consolidation phase, says RHB Retail Research - http://www.theedgemarkets.com/article/myeg-developing-consolidation-phase-says-rhb-retail-research (Share from StockHunter)

MYEG developing a consolidation phase, says RHB Retail Research - http://www.theedgemarkets.com/article/myeg-developing-consolidation-phase-says-rhb-retail-research (Share from StockHunter)

https://malaysiastock.biz/Company-Announcement.aspx?id=1277170

Good Q YoY 497% : QoQ 82%

(+1.7%)
MEMORANDUM OF UNDERSTANDING PMB TECHNOLOGY BERHAD ("PMBT" OR "THE COMPANY") MEMORANDUM OF UNDERSTANDING BETWEEN PMBT AND PERBADANAN PEMBANGUNAN EKONOMI SARAWAK
PMB TECHNOLOGY BERHAD

Type Announcement
Subject MEMORANDUM OF UNDERSTANDING
Description
PMB TECHNOLOGY BERHAD ("PMBT" OR "THE COMPANY") MEMORANDUM OF UNDERSTANDING BETWEEN PMBT AND PERBADANAN PEMBANGUNAN EKONOMI SARAWAK
The Board of Directors of PMBT is pleased to announce that the Company has on 26 November 2020, entered into a memorandum of understanding (“MOU”) with Perbadanan Pembangunan Ekonomi Sawarak (otherwise known as Sarawak Economic Development Corporation) (“SEDC”) to explore the potential collaboration for the development and operation of an integrated siloxane plant in Tanjung Kidurong, Bintulu, Sarawak.



Please refer to the attachment in relation to the MOU for further details.



This announcement is dated 26 November 2020.

Buy buy buy

Inari Amertron - 5G Rally Just Beginning… - http://klse.i3investor.com/m/blog/kenangaresearch/2020-11-26-story-h1536638682-Inari_Amertron_5G_Rally_Just_Beginning_hellip.jsp (Share from StockHunter)

MyEG's 9M results beats CGS-CIMB Research's forecast - https://www.thestar.com.my/business/business-news/2020/11/25/myeg039s-9m-results-beats-cgs-cimb-research039s-forecast (Share from StockHunter)

MyEG's 9M results beats CGS-CIMB Research's forecast - https://www.thestar.com.my/business/business-news/2020/11/25/myeg039s-9m-results-beats-cgs-cimb-research039s-forecast (Share from StockHunter)

MyEG's 9M results beats CGS-CIMB Research's forecast - https://www.thestar.com.my/business/business-news/2020/11/25/myeg039s-9m-results-beats-cgs-cimb-research039s-forecast (Share from StockHunter)

KUALA LUMPUR (Nov 25): Analysts have upgraded Inari Amertron Bhd to a "buy" as they expect the firm's earnings growth momentum to continue on strong fifth-generation (5G) smartphone demand.

RHB Investment Bank Research’s analyst Lee Meng Horng said in a note today Inari Amertron's Q1FY21 core earnings of MYR77.2 million exceeded his expectations on stronger-than-expected volume loadings and margins.

“The strong results set the mark for a better year in FY21 – this should persist in subsequent quarters to meet the growth and content for 5G smartphones,” said Lee, who favours Inari Amertron as a proxy to the growing 5G segment.

Sponsored Content

Post results, Lee increased Inari Amertron FY21 to FY23 earnings by 11% to 15.4% after factoring in stronger volume loadings and margins from the radio frequency (RF) business.

Lee, who upgraded Inari Amertron to buy from neutral, also revised up its target price to RM2.87 (from RM2.35).

CGS CIMB’s analyst Mohd Shanaz Noor Azam also said that Inari Amertron Q1FY21 results beat expectations, making up 32% of his FY21 forecasts due to higher-than-expected RF output utilisation.

“We expect its earnings growth momentum to continue on the back of new system-in-package (SiP) line capacity expansion and robust demand for new 5G smartphones,” he said in a note today.

He also raised Inari Amertron FY21 to FY23 earnings per share by 4% to 20% to reflect higher sales volumes.

“We expect Inari Amertron’s earnings to recover in FY21F, driven by higher demand for its RF chips on the back of the new 5G smartphone launch by a North America-based smartphone player,

“In addition, we expect a stronger sales recovery from Amertron Philippines in FY21 on the back of new customer wins; the plant is scheduled to begin mass production for its new customer in 2HFY21,” he said.

He upgraded Inari Amertron to add, and revised up its target price to RM3 (from RM2.35).

Meanwhile, MIDF Research’s analyst Foo Chuan Loong revised Inari Amertron FY21 to FY23 earnings estimates higher to between RM297.7 million to RM391.5 million, after the group’s results beat his expectation.

“We input higher revenue contributions primarily from the RF segment given the positive traction on 5G. In addition, we also expect the opto division to perform better due to the group’s effort to diversify its customer base,” he said in a note today.

Post his earnings adjustment, he derived a new target price of RM2.96 (previously RM2.05) on Inari Amertron.

“Moving forward, as the impact of Covid-19 dissipates, we view that the group’s volume loadings would improve greatly. This would primarily come from the RF segment as Inari is a close proxy to 5G,

“Operationally, we also expect the profit margin to improve continuously arising from various measures to control costs and capex. All factors considered, we are upgrading our call recommendation to buy from neutral previously,” said Foo.

At 10.11 am, Inari Amertron rose 7 sen or 2.83% to RM2.54, valuing the company at RM8.35 billions

Tech - Analysts upgrade Inari Amertron to 'buy' on strong earnings recovery - http://www.theedgemarkets.com/article/analysts-upgrade-inari-amertron-buy-strong-earnings-recovery (Share from StockHunter)

（吉隆坡24日讯）MyEG（MYEG，0138，主板科技股）在2020财年第三季，净赚7074万3000令吉，或每股赚2仙。

MyEG今天向交易所报备，当季营业额写1亿3609万6000令吉。

由于将财年截至日从6月30日，更换至9月30日，因此无从比较次季业绩表现。

若按季来看，净利上扬11%或696万令吉，营业额走高9.5%或1176万令吉，主要是2019冠状病毒病健康检查、杂货的线上销售，及在线保险与路税更新服务的贡献增加。

（吉隆坡24日讯）MyEG（MYEG，0138，主板科技股）在2020财年第三季，净赚7074万3000令吉，或每股赚2仙。

MyEG今天向交易所报备，当季营业额写1亿3609万6000令吉。

由于将财年截至日从6月30日，更换至9月30日，因此无从比较次季业绩表现。

若按季来看，净利上扬11%或696万令吉，营业额走高9.5%或1176万令吉，主要是2019冠状病毒病健康检查、杂货的线上销售，及在线保险与路税更新服务的贡献增加。